Reprogramming viral entry for precision therapeutics
Open Access Government · 16.04.2026 · 50 (1) · 132-137
DOI: 10.56367/oag-050-12372 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Access Government, erschienen am 16.04.2026. Verfasst von Lali K Medina Kauwe.
Abstract (Originalsprache)
Reprogramming viral entry for precision therapeutics Here, Cedars-Sinai Medical Center synthesize foundational adenovirus biology with key advances to present a unified model of penton base structure, function, and translational reprogramming. Efficient intracellular delivery – specifically escape from the endosomal compartment into the cytosol – remains one of the most formidable challenges in nucleic acid and macromolecular therapeutics.1 Viruses solve this problem through evolutionarily refined mechanisms that integrate receptor targeting, intracellular trafficking, and membrane disruption.2 Among these viral solutions, the adenovirus penton base stands out as a structurally discrete yet biologically powerful capsid protein that orchestrates internalization and endosomal escape.
Zitieren
APA
Kauwe, L. K. M. (2026). Reprogramming viral entry for precision therapeutics. Open Access Government, 50(1), 132-137. https://doi.org/10.56367/oag-050-12372
Vancouver
Kauwe LKM. Reprogramming viral entry for precision therapeutics. Open Access Government. 2026;50(1):132-137. doi:10.56367/oag-050-12372
BibTeX
@article{Kauwe2026,
author = {Kauwe, Lali K Medina},
title = {Reprogramming viral entry for precision therapeutics},
journal = {Open Access Government},
year = {2026},
volume = {50},
number = {1},
pages = {132--137},
doi = {10.56367/oag-050-12372}
}
EUVIMED